Articles tagged with Sars Cov 2
A study of 1.2 million symptomatic adults found that unvaccinated individuals had a higher risk of infection with SARS-CoV-2 compared to vaccinated adults. The analysis suggests that vaccination significantly reduces the risk of symptomatic COVID-19.
A study published in PNAS found that trust and knowledge about vaccination are stronger predictors of vaccination than Covid-specific factors. Background beliefs and behavior regarding vaccination in general were more than twice as predictive of the change in vaccination as beliefs about the pandemic itself.
Researchers from Göttingen University and Hannover Medical School have detected changes in heart muscle tissue of people who died from Covid-19. The study used innovative X-ray imaging to visualize the affected tissue in three dimensions, revealing a network of chaotic vessel formations.
New research reveals that COVID-19 vaccinated kidney transplant recipients have impaired antibody responses against emerging SARS-CoV-2 variants, including B.1.351 and B.1.617.2. The study found that these patients require additional vaccinations to maintain high levels of neutralizing antibodies.
A survey of 17,302 healthcare workers in 57 countries found that male participants and nurses had higher preparedness scores than women and doctors. Preparedness varied across national wealth and sociodemographic characteristics, with East Asia and the Pacific having significantly higher scores.
Despite receiving three vaccinations, kidney transplant patients have inadequate cellular and humoral protection against SARS-CoV-2, with around 90% showing little to no protection. Researchers are now investigating the efficacy and safety of a human antibody cocktail in these patients.
A novel quantum-based sensor has been developed to detect the SARS-CoV-2 virus with high accuracy and speed. The sensor uses nitrogen vacancy centers in diamond to detect minute perturbations in the presence of viral RNA, enabling fast and reliable detection.
A new aptasensor has been designed to detect the SARS-CoV-2 virus in saliva samples, offering higher sensitivity than antigen-based sensors. The sensor can detect concentrations as low as 0.5 nanomolars and works quickly and cheaply.
Researchers found that mRNA vaccines were highly effective (86%) in preventing SARS-CoV-2-related deaths among vaccinated individuals, especially in the elderly population. However, vaccine effectiveness against infection was lower (69%) and decreased with increasing age and comorbidity burden.
Researchers at Binghamton University developed a new methodology called E-beacon that can detect SARS-CoV-2 with reliable results in under 2 hours. The E-beacon uses enzymatic beacons to recognize specific sequences in the virus' spike gene, producing a brighter light signal with increasing virus nucleic acid presence.
The study found that two doses of Moderna and Pfizer vaccines produced higher antibody concentrations than a single dose of Johnson & Johnson vaccine, with levels more than 10 times higher for recovered COVID-19 patients. The analysis also showed that the Moderna vaccine had the lowest risk for breakthrough infections.
A study of 685 Italian children found that certain factors, such as age and comorbidities, are associated with severe gastrointestinal symptoms. The research identified key risk factors for severe GI symptoms in this population, shedding light on the complex interactions between SARS-CoV-2 infection and the immune system.
The Lancet infographic reviews COVID-19 diagnostic tests, highlighting their strengths and limitations. The study suggests that improved test accuracy could aid in pandemic control measures.
Researchers have discovered unique antibody-like proteins from sharks that can prevent the COVID-19 virus and its variants from infecting human cells. These shark-derived protein 'VNARs' are a promising new tool in the fight against SARS-CoV-2, with potential applications for future coronavirus outbreaks.
The study estimates the risk of severe outcomes among symptomatic children aged 0-17 years in the European Union, with hospitalization rates highest among youngest age groups. The authors also note that most children with symptomatic COVID-19 have a low risk of death or hospitalization.
A new study published in PLOS Computational Biology found that the order of COVID-19 symptoms varies depending on the SARS-CoV-2 variant. In the USA, cough was most likely to be the first symptom, while fever and diarrhea were more common third symptoms.
A new study suggests that breakthrough infections generate 'super immunity' to COVID-19, providing a robust immune response against the delta variant and potentially other variants. The study found that antibodies generated from breakthrough cases were 1,000% more effective than those from vaccinated individuals.
Recent preclinical study results demonstrate the Spike Ferritin Nanoparticle (SpFN) COVID-19 vaccine developed by WRAIR elicits potent immune responses and offers broad protection against SARS-CoV-2 variants and other coronaviruses. The SpFN vaccine uses a ferritin platform to present multiple copies of the coronavirus spike protein, i...
A new study warns that Omicron could lead to 100,273 fewer elective operations performed over the three winter months due to increased hospital admissions and COVID-19 patients. The model used NHS England data from September 2020 to July 2021 to project elective surgery activity based on the number of COVID-19 patients in hospital.
The University of Ottawa's CoVaRR-Net has received a $9 million grant extension to continue its rapid research on COVID variants, including the Omicron variant. This renewed funding will allow researchers to accelerate their work and keep policymakers informed of their latest findings.
Leading scientists recommend a new scientific approach called 'living evidence' that provides rigorous and trustworthy summaries of relevant research in real-time. This system aims to overcome the challenges of rapidly shifting research evidence and inform informed decisions.
A novel vaccine, TOH-Vac1, replicates inside the body's cells and generates a powerful immune response in mice and monkeys. The vaccine is based on a strain of vaccinia virus used to vaccinate against smallpox and can be programmed to protect against multiple variants.
The CDC found flaws in the assay design and contamination of one component, leading to false positive reactivity in negative controls. A redesign and improved quality control measures have since been implemented.
A Trinity College study found that severe COVID-19 patients who received care outside of an ICU had a higher mortality rate compared to those in the ICU. The study highlights Ireland's shortage of ICU beds and emphasizes the need for increased critical care capacity.
A review of 95 studies revealed that the percentage of asymptomatic COVID-19 cases varies significantly between individuals with confirmed infections and those who underwent testing. The analysis provides valuable insights into the prevalence of asymptomatic infections worldwide.
A clinical trial has revealed that COVID-19 patients on ventilators have less surfactant in their lungs due to the virus. The researchers suggest that giving extra surfactant for a longer period could help save lives by supporting breathing and allowing lung cells to repair after the infection passes.
A new study from the University of Georgia found that overweight youth are developing signs of artery stiffness, a significant risk factor for cardiovascular disease. Researchers measured visceral fat levels and arterial stiffness in over 600 children, adolescents, and young adults, revealing higher levels of visceral fat and arterial ...
A KAUST-led team developed a biosensor that can detect biomolecules, including the COVID-19 spike protein, with high sensitivity and selectivity. The device uses solid-state metal oxide transistors and can be used to diagnose multiple diseases quickly and easily.
Scientists have developed a fusion protein that successfully blocks replication of SARS-CoV-2 and related viruses in cell culture tests. The protein combines ACE2 with human antibody fragments, providing reliable protection against future mutations.
Researchers found that the SARS-CoV-2 N-protein accelerates the formation of amyloid fibrils in test tube experiments, interacting with α-synuclein protein. This interaction may contribute to the development of Parkinson's disease in COVID-19 patients.
A research team at Aarhus University has developed an RNA aptamer that attaches to the surface of SARS-CoV-2 virus particles, preventing it from entering human cells. This molecule is cheaper and easier to manufacture than current antibodies, making it a promising tool for detecting covid-19 infection.
A study published in CMAJ found that hospital health care workers in Quebec had high seroprevalence of SARS-CoV-2 antibodies after the first wave of the COVID-19 pandemic. The highest rates were reported in hospitals with outbreaks, particularly those from older facilities.
Researchers developed an RNA-based breath test called the Bubbler that can detect SARS-CoV-2 in exhaled breath, revealing a more direct indicator of current infection. The test also provides additional information on viral load and strain identity.
A new guideline outlines 13 recommendations to address health inequities exacerbated by COVID-19, including addressing racism and poverty. Implementing these policy changes can help reduce the burden of COVID-19 on marginalized communities.
A new study found that Omicron's immune-evading capabilities are significant, but some vaccinated and previously infected individuals have 'stronger' protection. However, the protection from Omicron may be compromised over time.
Researchers at UCLA have identified rare T cells capable of targeting a protein found in SARS-CoV-2 and other coronaviruses. By adding a fragment of this protein to vaccines, they hope to create a longer-lasting immune response and increase protection against new variants. This breakthrough could lead to more effective COVID-19 vaccines.
Scientists at Gladstone Institutes developed a new class of antiviral therapy that can track the evolution of SARS-CoV-2, reducing the chance of reduced efficacy against new variants. The single-dose intranasal treatment showed significant reduction in viral load and prevented disease in animals.
A new UC Davis study tracks firearm violence, assault, and homicide in 13 major US cities by zip code, revealing stark disparities. Firearm violence increased 29.3%, homicides by 27.7%, while robberies decreased 23.3% and rapes by 31.4% during the first five months of the pandemic.
Rutgers Robert Wood Johnson Medical School is part of a $470 million RECOVER initiative studying post-acute sequelae of COVID-19 (PASC) in children. The study aims to investigate long-term effects, symptoms and treatments for PASC, such as Multisystem Inflammatory Syndrome in Children (MIS-C).
The Parallel Amplified Saliva rapid POint-of-caRe Test (PASPORT) has been developed with a two-stage process, producing results in minutes and enabling sensitivity comparable to laboratory-based PCR tests. The test's sensitivity was 97% in a clinical study involving over 100 participants.
Researchers found that a combination of natural infection and vaccination produces maximally potent antibodies against COVID-19. The study suggests that repeated exposures to the spike protein can improve the immune system's ability to produce high-quality antibodies against variants.
Researchers developed a novel computer simulation method that can analyze key proteins in the reproductive cycle of SARS-CoV-2, promising to accelerate the search for bioactive compounds against COVID-19. The method estimates a reduction in research time from two to three years to under a year.
A study published in Journal of Biological Rhythms found that antibody levels are higher when healthcare workers received the SARS-CoV-2 vaccine in the afternoon. The study suggests that circadian rhythms may play a role in regulating immune responses to COVID-19 vaccination.
Researchers have identified hundreds of tiny llama antibodies called nanobodies that target the SARS-CoV-2 spike protein, which current therapies do not address. Combining these nanobodies into cocktails could create potent treatments against new variants, including Omicron.
A study examining autopsy tissue samples from COVID-19 patients found frequent and extensive blood clots within heart vessels, but no typical endothelial cell changes. Instead, hypercoagulability of the blood caused by activated neutrophils was detected as a likely culprit.
Researchers at Drexel University found a 61% decline in new COVID-19 cases after closing indoor dining during the first two waves of the pandemic. Closing indoor dining could be a tool to curb the spread of new variants globally, alongside other measures such as vaccination and social distancing.
Researchers at Hokkaido University and Texas A¼M University identified a key mechanism used by SARS-CoV-2 to evade host immune systems, targeting the MHC class I pathway. The study found that the virus suppresses the activation of this pathway using the ORF6 protein, allowing it to persist in the body and infect others.
A recent study suggests that severe COVID-19 may cause long-term damage to the testes, leading to reduced sperm count and quality. The virus's interaction with testicular cells and potential effects on fertility are being explored through an experimental framework.
Researchers report that combining infection and vaccination produces high-quality antibodies effective against COVID-19 variants. The study found that prior-infected individuals who received a vaccine had potent antibodies against new variants, contrary to previous findings suggesting reduced potency.
A large field hospital study shows that a rapid Covid-19 test is as accurate as PCR detection, with high sensitivity rates for both symptomatic and asymptomatic patients. The rapid antigen test's ease of use, time savings, and cost effectiveness make it an ideal solution to reduce testing disparities in medically underserved communities.
A study found that obesity is associated with severe COVID-19 outcomes, including hospital admission or death. Additionally, accelerated immunosenescence may be a key mechanism explaining the relationship between obesity and T2DM in severe COVID-19. Vaccination effectiveness may also be impacted by metabolic disorders.
Researchers have discovered miniature antibodies derived from llamas that can neutralize SARS-CoV-2 and its variants, including Delta and Omicron. The nanobodies' small size allows them to access hard-to-reach spots on the virus, making them a potential treatment against future variants.
Researchers find SARS-CoV-2 infects sustentacular cells in the olfactory epithelium of COVID-19 patients, replicating vigorously within these cells. The virus does not appear to infect nerve cells, instead affecting sensory neurons indirectly through insufficient support from sustentacular cells.
Heidelberg researchers have created a rapid process for 3D imaging of cells using soft X-ray tomography, enabling high-resolution images in just five to ten minutes. This technology provides valuable insights into viral diseases and their impact on infected cells.
A new chewing gum infused with plant-grown ACE2 protein can neutralize the SARS-CoV-2 virus in saliva, potentially reducing transmission risk. The gum, developed by researchers at the University of Pennsylvania, was tested on saliva samples from COVID-19 patients and found to significantly reduce viral load.
Scientists at La Jolla Institute for Immunology and MIT have discovered a new adjuvant called SMNP, which combines saponin and TLR agonist to boost the protective power of vaccines. The study found that SMNP triggers a strong immune response in mice, promoting lymphatic drainage and activating multiple parts of the immune system.
A study by Imperial College London found that the first SARS-CoV-2 spike protein encountered through vaccination or infection influences subsequent immune responses to current and future variants. This 'immune imprinting' affects the rate of decay of protection and impacts antibody levels over time.
Researchers at Georgia State University have developed a new candidate antiviral drug, 4’-FlU, which shows potent activity against SARS-CoV-2 and other respiratory RNA viruses. The study demonstrates that 4’-FlU induces termination of the viral polymerase, aborting replication and offering a strong therapeutic asset.
Researchers found that damaged telomeres increase the expression of ACE2, the human SARS-CoV-2 cell receptor, leading to increased viral susceptibility in the elderly. This DNA damage response is triggered by telomere shortening and dysfunction in aging cells.
A recent study published in PLOS Pathogens found that the COVID-19 Delta variant may have a reduced ability to be neutralized by vaccines. The researchers analyzed serum samples from vaccinated individuals and found that the Delta variant was more effective at evading vaccine-induced immunity than other variants, such as Beta and Alpha.